Impact of Type of Liver Resection on the Outcome of Colorectal Liver Metastases: a Case-matched Analysis
Overview
Oncology
Authors
Affiliations
Background: Wedge resection (WR) for colorectal liver metastases (CLM) has become more common in an attempt to preserve liver parenchyma. However, some investigator have reported that WR is associated with a higher incidence of positive margin and an inferior survival compared with anatomic resection (AR) 1.
Objectives: This study evaluated survival, margin status, and pattern of recurrence of patients with CLM treated with WR or AR.
Methods: We identified 208 consecutive patients, in a single institutional database from 1995 to 2004, who underwent either WR or AR. WR was defined as a nonanatomic resection and AR was defined as single resection of one or two liver segments. Patients with combined WR-AR and patients requiring resection of more than two segments or radiofrequency ablation were excluded from the analysis.
Results: One hundred six patients underwent WR and 102 patients had AR. There were no differences in the rate of positive surgical margin (P = 0.146), overall recurrence rates (P = 0.211), and patterns of recurrence between the two groups (P = 0.468). The median survival was 32 months for WR and 42 for AR, with 5-year survival rates of 29% and 27% respectively, with no significant difference (P = 0.308). Morbidity was similar between the two groups.
Conclusions: WR is a safe procedure and does not disadvantage the patients in terms of tumor recurrence and overall survival.
Wang K, Liu Y, Hao M, Li H, Liang X, Yuan D World J Surg Oncol. 2023; 21(1):241.
PMID: 37553574 PMC: 10408219. DOI: 10.1186/s12957-023-03127-1.
Ratti F, Cipriani F, Fiorentini G, Burgio V, Ronzoni M, Della Corte A Cancers (Basel). 2021; 13(5).
PMID: 33803257 PMC: 7967178. DOI: 10.3390/cancers13051178.
Fiorentini G, Ratti F, Cipriani F, Aldrighetti L Ann Surg Oncol. 2021; 28(11):6828-6829.
PMID: 33791904 DOI: 10.1245/s10434-021-09957-1.
van der Heijde N, Ratti F, Aldrighetti L, Benedetti Cacciaguerra A, Can M, DHondt M Surg Endosc. 2020; 35(11):6139-6149.
PMID: 33140153 PMC: 8523385. DOI: 10.1007/s00464-020-08109-y.
Deng G, Li H, Jia G, Fang D, Tang Y, Xie J Cancer Med. 2019; 8(14):6165-6175.
PMID: 31464101 PMC: 6797569. DOI: 10.1002/cam4.2515.